Sera Prognostics Shares Spike on Positive Study Results for PreTRM Preterm Birth Test
The company said the study met its two primary outcomes of reducing severe neonatal morbidity or neonatal death and decreasing the length of neonatal hospital stays.
Natera Launches Follow-On Stock Offering at $35 Per Share
Natera is offering 11,430,000 common shares at $35 per share, with additional shares available as an option to underwriters.
Broader Market Drags 360Dx Top 30 Down in September
Of the 30 diagnostic companies in the index, 29 saw their share prices decline, while only one firm saw its stock price rise.
360Dx Top 30 Tumbles in August
Of the 30 diagnostic companies in the index, 22 saw their share prices decline, while eight firms saw stock prices rise.
360Dx Top 30 Drops 11 Percent in April, Following Broader Market Trends
Of the 30 diagnostic companies in the index, every firm's share price dropped by at least 1 percent.
Apr 1, 2022
360Dx Top 30 Falls Slightly in March
Feb 1, 2022
360Dx Top 30 Plummets 17 Percent in January
Jan 4, 2022
360Dx Index Rises 20 Percent in 2021
Oct 23, 2020